Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
STANGER KENT W
   2. Issuer Name and Ticker or Trading Symbol
MERIT MEDICAL SYSTEMS INC [MMSI] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chief Financial Officer
(Last)
(First)
(Middle)
1600 W MERIT PARKWAY		 3. Date of Earliest Transaction (Month/Day/Year)
06/05/2014
(Street)

SOUTH JORDAN, UT 84095		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, No Par Value               79,100 I By 401(k) plan (1)
Common Stock, No Par Value               4,271 (2) D  
Common Stock, No Par Value               60,001 I Family Limited Liability Company (3)
Common Stock, No Par Value 06/05/2014   M   10,165 A $ 9.7 725,001 D  
Common Stock, No Par Value 06/05/2014   S   10,165 D $ 14.1086 (4) 714,836 D  
Common Stock, No Par Value 06/06/2014   M   3,768 A $ 9.7 718,604 D  
Common Stock, No Par Value 06/06/2014   S   3,768 D $ 14.1045 (5) 714,836 D  
Common Stock, No Par Value 06/09/2014   M   8,204 A $ 9.7 723,040 D  
Common Stock, No Par Value 06/09/2014   S   8,204 D $ 14.1201 (6) 714,836 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-qualified stock options (right to buy) $ 12.02             12/18/2004 12/18/2014 Common Stock 25,000   25,000 D  
Non-qualified stock options (right to buy) $ 11.41             05/25/2005 05/25/2015 Common Stock 18,750   18,750 D  
Non-qualified stock options (right to buy) $ 9.71             12/28/2005 12/28/2015 Common Stock 25,000   25,000 D  
Non-qualified stock options (right to buy) $ 9.7 06/05/2014   M     10,165 06/27/2008(7) 06/27/2014 Common Stock 10,165 $ 0 11,972 D  
Non-qualified stock options (right to buy) $ 9.7 06/06/2014   M     3,768 06/27/2008(7) 06/27/2014 Common Stock 3,768 $ 0 8,204 D  
Non-qualified stock options (right to buy) $ 9.7 06/09/2014   M     8,204 06/27/2008(7) 06/27/2014 Common Stock 8,204 $ 0 0 D  
Non-qualified stock options (right to buy) $ 11.53             05/21/2009(8) 05/21/2015 Common Stock 43,750   43,750 D  
Non-qualified stock options (right to buy) $ 13.82             09/26/2010(9) 09/26/2016 Common Stock 25,000   25,000 D  
Non-qualified stock options (right to buy) $ 13.75             08/11/2012(10) 08/11/2018 Common Stock 80,000   80,000 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
STANGER KENT W
1600 W MERIT PARKWAY
SOUTH JORDAN, UT 84095		   X     Chief Financial Officer  

Signatures

 Kent W. Stanger   06/09/2014
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Represents plan holdings as of 06/09/2014.
(2) Employee stock purchase plan holdings as of 06/05/2014.
(3) This report shall not be deemed an admission that the reporting person is the beneficial owner of the securities held by K.W.S. Properties LC.
(4) The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.10 to $14.13, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
(5) The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.10 to $14.12, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
(6) The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.10 to $14.15, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
(7) Becomes exercisable in equal annual installments of 20% commencing 06/27/2008.
(8) Becomes exercisable in equal annual installments of 20% commencing 05/21/2009.
(9) Becomes exercisable in equal annual installments of 20% commencing 09/26/2010.
(10) Becomes exercisable in equal annual installments of 20% commencing 08/11/2012.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.